Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors - Summary - MDSpire

Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors

  • By

  • Sebastian Galeano

  • Carmem Bonfim

  • Amado Karduss

  • Gregorio Jaimovich

  • Andrés Gómez-De León

  • Gustavo Bettarello

  • Anderson Simione

  • Cinthya Correa

  • Helen Baldomero

  • Daniel Neumann

  • Ana Lisa Basquiera

  • Mariano Berro

  • Guillermina Remaggi

  • Ariel Amaru

  • Fernando Barroso

  • Adriana Seber

  • Francisco Barriga

  • Julia Palma

  • Bárbara Puga

  • Matías Sánchez

  • Juan Manuel Herrera

  • Calixto Hernández

  • David Gómez-Almaguer

  • Félix Gaytán Morales

  • Guillermo J. Ruiz-Argüelles

  • Ninotzka Mendoza

  • María Liz Benítez

  • Alfredo Wong

  • Carolina Pagés

  • Marcos Hernández

  • Dietger Niederwieser

  • Damiano Rondelli

  • Cristóbal Frutos

  • April 18, 2025

  • 0 min

Share

Objective:

To report on hematopoietic stem cell transplantation (HCT) activity in Latin America from 2019 to 2022, focusing on the impact of COVID-19 and trends in haploidentical donors, emphasizing their increasing relevance.

Key Findings:
  • Total of 6767 HCT reported in 2022, with 39% being alloHCT and 61% autoHCT, reflecting a shift in donor preferences.
  • Pediatric HCT comprised 1121 cases, with 82% alloHCT and 18% autoHCT, indicating a strong reliance on alloHCT in younger populations.
  • Adult HCT totaled 5646, with 31% alloHCT and 69% autoHCT, suggesting a trend towards more autoHCT in adults.
  • Transplant rate in 2022 was 103 HCT per 10 million population, a critical metric for assessing healthcare access.
Interpretation:

The data indicates a significant volume of HCT activity in Latin America, with a notable prevalence of autoHCT over alloHCT, and highlights the increasing role of haploidentical donors, particularly in the context of the COVID-19 pandemic.

Limitations:
  • Survey responses were not received from all transplant centers, potentially underrepresenting total activity and skewing results.
  • Data on additional HCT beyond the first transplant was not included, limiting the comprehensiveness of the findings.
Conclusion:

The survey provides valuable insights into HCT trends in Latin America during the COVID-19 pandemic, emphasizing the importance of haploidentical donors in the region and suggesting areas for future research.

Original Source(s)

Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors

  • by Sebastian Galeano, Carmem Bonfim, Amado Karduss, Gregorio Jaimovich, Andrés Gómez-De León, Gustavo Bettarello, Anderson Simione, Cinthya Correa, Helen Baldomero, Daniel Neumann, Ana Lisa Basquiera, Mariano Berro, Guillermina Remaggi, Ariel Amaru, Fernando Barroso, Adriana Seber, Francisco Barriga, Julia Palma, Bárbara Puga, Matías Sánchez, Juan Manuel Herrera, Calixto Hernández, David Gómez-Almaguer, Félix Gaytán Morales, Guillermo J. Ruiz-Argüelles, Ninotzka Mendoza, María Liz Benítez, Alfredo Wong, Carolina Pagés, Marcos Hernández, Dietger Niederwieser, Damiano Rondelli, Cristóbal Frutos

  • April 18, 2025

Related Content

Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease

Long-term Sequelae Following Dengue Infection vs SARS-CoV-2 Infection in a Pediatric Population: A Retrospective Cohort Study

Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19